Phase III

The program becomes mature (Phase III) when it starts to address the intrinsic wastes through more complex recycling and reuse activities, more fundamental changes to the process, changes in the raw material or catalysts, or reformulation of the product. Emphasis has now shifted to the process itself. 

The project will progress in stages, beginning with a waste audit carried out by an audit team. The audit team consists of a waste audit expert, a sector specialist, a financial expert, an economist/ marketing expert, and an expert in product life-cycle assessments. The audit team also supports the project in its different stages. 

The following seven outputs will be produced by the audit team9  

Availability of material balances for selected unit process operations (Table 1.1) 

Obvious waste reduction measures identified and implementation initiated (improved housekeeping) (Table 1.2) 

Toward the end of a phase II trial, the sponsoring company often meets with the FDA to present clinical and late animal data collected. Plans for moving forward into phase III trials are also covered. Depending on the data, the FDA may recommend specific clinical tests or additional animal trials to clarify any questions. 

---

Acetyl-i-carnitine (4) is marketed in Italy for dementia as of this writing it is also in Phase III clinical trials in the United States and Europe. In a double-blind, placebo-controUed clinical trial over a one-year period involving 130 patients with clinically diagnosed AD, a slower rate of deterioration in 13 of the 14 outcome measures was observed in the dmg-treated group (28). Earfler smaller scale pilot studies in demented patients had also shown some improvement of various behavioral and cognitive functions (29). 

Phase III Dmg samples are made available to select clinicians for use on large numbers of patients to obtain statistically significant data for safety and efficacy. 

Phase III Synthesis. (/) Identify options identify opportunities, target problem areas, and confirm options. 2) Evaluate options technical, environmental, and economic. (J) Prepare action plan waste reduction plan, production efficiency plan, and training. 

Year is year of launch in the U.S. market unless indicated Pre-Cl = preclinical, Ph III = phase III clinical trials (status as of Feb. 1990). 

U.S. —Canada Memorandum of Intent on Transbounday Air Pollution, Atmospheric Sciences and Analysis Work Group 2 Phase III Final Report,U.S. Environmental Protection Agency, Washington, D.C., 1983. 

Phase III in Fig. 5 is marked by a cooling of the bond line, which causes the bulk viscosity of the adhesive to rise. During phase IV, another sharp increase in viscosity is observed. This is caused by the re-crystallization of the polymer... 

Phases I and II have eovered planning and undertaking a P2 audit, resulting in the preparation of a material balance for each unit operation. Phase III represents the interpretation of the material balance, to identify process areas or components of concern. 

Analysis of DIERS Phase III Blowdown Tests, DIERS/ AIChE, 1986, 151 pages. 

Drug Animal tests, Phase Phase II Phase III NDA Ongoing... 

FIGURE 9.2 Histograms showing the number of new drag entities entering phase I clinical development (blue bars), and concomitantly the number entering phase III development as a function of year. Adapted from [2]. 

CTI charge-tranfer resistance between electrode and solid electrolyte phase III.6... 

SR/sol double-layer resistance between solid electrolyte/solution or battery electrolyte phases III. 6... 

Patomomycin This oral aminoglycoside was first shown to be effective as a topical treatment for cutaneous leishmaniasis, and later as a parenteral drug against visceral leishmaniasis. Phase III clinical trials were completed in 2005 in India, 15 years after the potential of this component for treating viscer al leishmaniasis was discovered. It is currently not registered for this use. 

Haemolymphatic stage (acute stage) For the last two decades, the first line treatment for the acute stage are Pentamidine and Suramin [2]. One compound, the prodrug DB 289 (a diamidine), is currently in phase III clinical trials. 

O Brien S, Moore JO, Boyd TE et al (2007) Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia. J Clin Oncol 25(9) 1114-1120... 

OPG has been shown to reduce bone turnover in postmenopausal women. More recently, Denusomab, an anti-RANKL mAb, has been tested for its ability to increase BMD and to reduce bone turnover. Results were promising and clinical phase III studies with fracture endpoints are presently under way. 

Bosentan (Tracleer ) Actelion, Switzerland ETA/ETB receptor Grade III and IV PAH and chronic thromboembolic pulmonary hypertension (European approval in 2002 as orphan medicine) Program for CHF was terminated in phase III... 

ABT-627 (Atrasentan) Abbott Laboratories, USA ETA receptor Hormone-refractory prostate cancer, stage IV (phase III)... 

Ro-61-0612 (Tezosentan) Actelion, Switzerland ETA/ETB receptor AHF (phase III, discontinued)... 

---